Alvotech ALVO
NASDAQ ALVO
$4.43 +0.16 (+3.75%)
At close: Aug 21, 2026 · 4:00 PM EDT

Alvotech (ALVO) Depreciation & Amortization (CF) (2021 - 2026)

Alvotech's (ALVO) quarterly Depreciation & Amortization (CF) came in at $10.3 million in Q1 2026, up 24.56% YoY from $8.3 million in Q1 2025, and little changed on a QoQ basis from $10.3 million in Q3 2025.

Alvotech (ALVO) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $10.3 million in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 24.56% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.5 million (down 46.92% YoY) and the FY2023 annual result came in at $24.2 million, up 18.62% from the prior year.
  • Depreciation & Amortization (CF) was little changed at $10.3 million in Q1 2026, from $10.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $31.3 million in Q4 2024 to a low of $4.7 million in Q1 2022.
  • A 5-year average of $8.9 million and a median of $7.4 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) advanced 3.2% — and 2024, when it jumped 365.44%.
  • Tracing ALVO's Depreciation & Amortization (CF) over 5 years: stood at $5.3 million in 2022, then gained by 26.29% to $6.7 million in 2023, then jumped by 365.44% to $31.3 million in 2024, then tumbled by 67.15% to $10.3 million in 2025, then grew by 0.05% to $10.3 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $10.3 million (Q1 2026), $10.3 million (Q3 2025), and $8.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 241.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Alvotech 1.30 Bn 1.30 Bn 5.09 Mn 10.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.29 Mn
Mar 31, 2026 10.29 Mn
Sep 30, 2025 10.28 Mn
Sep 30, 2025 10.28 Mn
Jun 30, 2025 8.90 Mn
Jun 30, 2025 8.90 Mn
Mar 31, 2025 8.26 Mn
Mar 31, 2025 8.26 Mn
Dec 31, 2024 31.30 Mn
Dec 31, 2024 31.30 Mn
Sep 30, 2024 8.40 Mn
Sep 30, 2024 8.40 Mn
Jun 30, 2024 7.56 Mn
Jun 30, 2024 7.56 Mn
Mar 31, 2024 7.19 Mn
Mar 31, 2024 7.19 Mn
Dec 31, 2023 6.73 Mn
Dec 31, 2023 6.73 Mn
Jun 30, 2023 6.09 Mn
Jun 30, 2023 6.09 Mn